COVID-19 vaccine: Oxford, Pfizer or Moderna, which is better

New Delhi, Nov 23: The phase 3 interim analysis of the Oxford/AstraZeneca Covid-19 vaccine candidate has shown as 70.4 per cent efficacy in preventing the disease. In two different dosing regiments, the vaccine AZD1222, showed the efficacy of 90 per cent

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/35YXZ0p

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post